The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.

The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief ...

Immediate symptomatic relief and long-term neuroimmunomodulation seen with acupressure combined with pharmacotherapy ...

HealthDay News — Quadrivalent human papillomavirus (HPV) vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth, according to a study ...

A nationwide voluntary recall has been issued for 22 lots of Argatroban Injection due to the presence of multi-material particulate contamination, posing potential life-threatening risks.

Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...

Vanda Pharmaceuticals has paused the clinical program for VQW-765 after a phase 3 trial evaluating the drug for social anxiety disorder failed to show significant distress reduction compared with ...

The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.

Michelle Min, MD, MS, met with the MPR team to discuss multidisciplinary collaboration in the treatment of cutaneous lupus, as well as the current standard of care and emerging therapies on the ...

Real-world GPP data show low uptake of targeted IL-36 inhibitors and persistent reliance on corticosteroids and non-GPP ...

Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...

Dr Ablon discusses important key points providers should keep in mind during their evaluations of patients seeking aesthetic ...